Comparative study of dermaroller therapy versus trichloroacetic acid CROSS for the treatment of atrophic acne scars
DOI:
https://doi.org/10.66344/jpad.25.2.2015.93Keywords:
Acne scars, dermaroller, TCA CROSS, atrophic, improvementAbstract
Objective To compare the efficacy and safety of dermaroller treatment with that of TCA CROSS in acne scars.Methods We selected thirty patients of atrophic acne scars for the study. Group I patients underwent four sessions of dermaroller therapy four weeks apart. Group II were treated with four sessions of TCA CROSS technique four weeks apart.Results After four sessions of dermaroller and TCA CROSS each, marked improvement was seen in 40% patients in the dermaroller group and in 60% patients in the CROSS group. Moderate improvement was seen in 40% patients in dermaroller group and in 26.6% patients in the CROSS group and mild improvement was seen in 20% patients in dermaroller group and 13.3% patients in the CROSS group. Side effects were mild and infrequent in both groups.Conclusion Both treatments are equally effective and safe for the treatment of acne scars.References
Cotterill JA, Cunliffe WJ. Suicide in dermatologic patients. Br J Dermatol. 1997;137:246-50.
Koo JY, Smith LL. Psychologic aspects of acne. Pediatr Dermatol. 1991;8:185-8.
Koo J. The psychosocial impact of acne: patients' perceptions. J Am Acad Dermatol. 1995;32:S26-S30.
Layton AM, Henderson CA, Cunliffe WJ. A clinical evaluation of acne scarring and its incidence. Clin Exp Dermatol. 1994;19:303-8.
Rivera AE. Acne scarring: A review and current treatment modalities. J Am Acad Dermatol. 2008;59:659-76.
Goodman GJ, Baron JA. The management of postacne scarring. Dermatol Surg. 2007;33:1175-88.
Tsao SS, Dover JS, Arndt KA, Kaminer MS. Scar management: keloid, hypertrophic, atrophic, and acne scars. Semin Cutan Med Surg. 2002;21:46-75.
Jacob CI, Dover JS, Kaminer MS. Acne scarring: a classification system and review of treatment options. J Am Acad Dermatol. 2001;45:109-17.
Goodman GJ, Baron JA. Postacne scarring: a qualitative global scarring grading system. Dermatol Surg. 2006;32:1458-66.
Aust MC, Fernandes D, Kolokythas P et al. Percutaneous collagen induction therapy: an alternative treatment for scars, wrinkles, and skin laxity. Plast Reconstr Surg. 2008;121:1421-9.
Camirand A, Doucet J. Needle dermabrasion. Aesthetic Plast Surg. 1997;21:48-51.
Fabbrocini G, Fardella N, Monfrecola A et al. Acne scarring treatment using skin needling. Clin Exp Dermatol. 2009;34:874-9.
Lee JB, Chung WG, Kwahck H, Lee KH. Focal treatment of acne scars with trichloroacetic acid: chemical reconstruction of skin scars method. Dermatol Surg. 2002;28:1017-1021.
Fabbrocini G, Fardella N, Monfrecola A. Needling. In: Tosti A, Pie De Padova M, Beer K, editors. Acne Scars: Classification and Treatment. London: Informa Healthcare; 2010. pp. 57-290.
Jacob CL, Dover JS, Kaminer MS. Acne scarring: A classification system and review of treatment options. J Am Acad Dermatol. 2001;45:109-17.
Fabbrocini G, Annunziata MC, D'Arco V et al. Acne scars: pathogenesis, classification and treatment. Dermatol Res Pract. 2010;20:89-91.
Lee JB, Chung WG, Kwahck H, Lee KH. Focal treatment of acne scars with trichloroacetic acid: Chemical reconstruction of skin scars method. Dermatol Surg. 2002;28:1017-21.
Fabbrocini G, Cacciapuoti S, Fardella Net al. CROSS technique: Chemical reconstruction of skin scars method. Dermatol Ther. 2008;21:29-32.
Yug A, Lane JE, Howard MS, Kent DE. Histologic study of depressed acne scars treated with serial high-concentration (95%) trichloroacetic acid. Dermatol Surg. 2006;32:985.
Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
